SHS Private Equity

Due to the continuous growth of the different fund generations, SHS V is going to invest predominantly in already established corporations within the MedTech and adjacent sectors.

SHS takes part in transactions with a total volume of up to € 100m within the MedTech/Life Sciences business. SHS V provides between € 2m and € 30m as equity, but can engage in much larger transactions thanks to its distinctive network of co-investors.

Besides majorities, also minority investments are considered. Motives for an investment may have different origins. Our geographical focus is concentrated on the German-speaking countries as well as Scandinavia and the Benelux countries.

We are looking forward to hearing from you.